New nanomedicine approach for treating acute ischemic stroke
Next-generation nanomedicine for acute ischemic stroke
['FUNDING_OTHER'] · NANOMUSE, LLC · NIH-10603229
This study is testing a new way to deliver brain-protecting medications directly to the brain for people who have had a stroke, hoping to help them recover better after treatment.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NANOMUSE, LLC (nih funded) |
| Locations | 1 site (PRINCETON JUNCTION, UNITED STATES) |
| Trial ID | NIH-10603229 on ClinicalTrials.gov |
What this research studies
This research focuses on developing advanced nanocarriers to deliver neuroprotective drugs specifically to the brain during acute ischemic stroke. By utilizing a novel technology that binds to a specific brain marker, the researchers aim to significantly enhance drug delivery, improving outcomes for patients who have undergone mechanical thrombectomy. The study will explore the effectiveness of these nanocarriers loaded with corticosteroids in reducing brain damage and improving recovery after stroke. Patients may benefit from a more targeted treatment that addresses the secondary injuries caused by stroke.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced an acute ischemic stroke and are undergoing treatment.
Not a fit: Patients who have not had a stroke or those with other unrelated medical conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved recovery and reduced brain damage for stroke patients.
How similar studies have performed: Previous research has shown promise with similar nanocarrier approaches, indicating potential for success in this novel application.
Where this research is happening
PRINCETON JUNCTION, UNITED STATES
- NANOMUSE, LLC — PRINCETON JUNCTION, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BRENNER, JACOB — NANOMUSE, LLC
- Study coordinator: BRENNER, JACOB
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.